Receptor tyrosine kinases as target for anti-cancer therapy.
about
VEGFR-2 expression in human melanoma: revised assessment.Effect of the G375C and G346E achondroplasia mutations on FGFR3 activation.RETRACTED: Soluble Axl is generated by ADAM10-dependent cleavage and associates with Gas6 in mouse serumSuppression of cancer progression by MGAT1 shRNA knockdown.(124)I-iodopyridopyrimidinone for PET of Abl kinase-expressing tumors in vivo.Cancer metastasis therapeutic targets and drug discovery: emerging small-molecule protein kinase inhibitors.LRIG1 modulates cancer cell sensitivity to Smac mimetics by regulating TNFα expression and receptor tyrosine kinase signalingDifferentiation of cancer cell type and phenotype using quantum dot-gold nanoparticle sensor arrays.Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling.Quinazoline derivatives as potential anticancer agents: a patent review (2007 - 2010).Discovery of novel vascular endothelial growth factor receptor 2 inhibitors: a virtual screening approach.Targeting the E3 ubiquitin casitas B-lineage lymphoma decreases osteosarcoma cell growth and survival and reduces tumorigenesis.Design, synthesis, and in vitro antitumor activity evaluation of novel 4-pyrrylamino quinazoline derivatives.Probing the binding site of abl tyrosine kinase using in situ click chemistry.A small peptide promotes EphA2 kinase-dependent signaling by stabilizing EphA2 dimers.Shock block for improved immunotherapy
P2860
Q30423356-739458B3-DE6D-43C9-8B16-A1D9316735AAQ31056899-2EC5B624-6A5B-4281-B486-F71DF89BEAF3Q34097404-9DAF1160-638F-4823-A9BE-EE9BD526168CQ34407965-60878612-137A-44AD-ADD7-06A131E76692Q35609644-48A60254-64FB-4F75-B4FD-57754D05276AQ35609713-6A6D2BB3-E71E-4C41-A444-896BD037599BQ35803259-4CE43634-CCEF-454E-B1CC-A9A83A5F83B1Q36893261-B59A00B8-6847-421F-87BE-686514F5B4A1Q36984546-A83317A4-B2F9-4562-853B-63C595821122Q37992086-01B847C2-6783-4330-894A-17F71B5EF2F4Q39292974-064159DE-5D60-4FB0-9A72-8E16CF8D48BAQ39343202-C60A18A7-046E-4608-A283-C4EA26E4F2BAQ39478982-BD4525D0-C353-459D-9E63-364AFF6B1BDCQ39778716-2E61064E-C7A5-406D-B142-A301D5B89E31Q41867076-FE0C5AAD-EB5B-4E7D-AE35-1110823682DCQ42403322-43988711-7F1C-422A-987B-CFC48D08D55D
P2860
Receptor tyrosine kinases as target for anti-cancer therapy.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Receptor tyrosine kinases as target for anti-cancer therapy.
@ast
Receptor tyrosine kinases as target for anti-cancer therapy.
@en
Receptor tyrosine kinases as target for anti-cancer therapy.
@nl
type
label
Receptor tyrosine kinases as target for anti-cancer therapy.
@ast
Receptor tyrosine kinases as target for anti-cancer therapy.
@en
Receptor tyrosine kinases as target for anti-cancer therapy.
@nl
prefLabel
Receptor tyrosine kinases as target for anti-cancer therapy.
@ast
Receptor tyrosine kinases as target for anti-cancer therapy.
@en
Receptor tyrosine kinases as target for anti-cancer therapy.
@nl
P2093
P356
P1476
Receptor tyrosine kinases as target for anti-cancer therapy
@en
P2093
S Brunelleschi
P304
P356
10.2174/1381612023393530
P577
2002-01-01T00:00:00Z